February 15, 2019 | Childhood Cancer, ICCD, Infographic
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We’ve pulled together an infographic to show just what we mean with data c/o Cancer Research UK (CRUK) and a great initiative by Beads of Courage, Inc.
There’s still more to do, so show your support for a day when there is No More Pain and No More Loss for all children with cancer regardless of where they live in the world.


Company Details
Latest Content from Cuttsy + Cuttsy
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here’s why diversity matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Recruiting patients for clinical trials is one of pharma’s greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take…
Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial…
Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.
It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when…
Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. Find how to use colour effectively in your next clinical trial campaign.
With nearly a decade’s experience supporting clinical trials, find out why we think humanising trials through design is so important.
Throughout three fascinating days of conference, some key themes emerged that are impacting study teams and the effectiveness of their clinical trials on a daily basis.
